hat
Finasteride pafwa yo itilize nan terapi ranplasman òmòn pou fanm transganr akòz pwopriyete antiandrogen li yo, an konbinezon ak yon fòm estwojèn. Sepandan, yo te fè rechèch ti klinik nan itilize finasteride pou objektif sa a ki te fèt ak prèv nan efikasite limite.Anplis, yo te rekòmande prekosyon lè preskri finasteride fanm transganr, kòm finasteride ka asosye ak efè segondè tankou depresyon, enkyetid, ak komèt swisid ideasyon, sentòm ki patikilyèman répandans nan popilasyon an transganr ak nan lòt moun nan gwo risk deja.
eng
Finasteride is sometimes used in hormone replacement therapy for transgender women due to its antiandrogen properties, in combination with a form of estrogen . However, little clinical research of finasteride use for this purpose has been conducted and evidence of efficacy is limited.Moreover, caution has been recommended when prescribing finasteride to transgender women, as finasteride may be associated with side effects such as depression, anxiety, and suicidal ideation, symptoms that are particularly prevalent in the transgender population and in others at high risk already.